NatImmune natimmune.com


Public lists: Pharma Startups (4732)

NatImmune A/S has developed a product for replacement therapy of Mannan Binding Lectin (MBL) in patients carrying genetic pre-disposition to infections through a deficiency in the immune system. The project is partnered with ENZON Pharmaceuticals, Inc.

NatImmune A/S has developed a product for replacement therapy of Mannan Binding Lectin (MBL) in patients carrying genetic pre-disposition to infections through a deficiency in the immune system. The project is partnered with ENZON Pharmaceuticals, In...Show all

Company (Alive / Active)

Phone: 057-022-3560

Fax:

3 Fruebjergvej
02100
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NatImmune $0M Nov 30, 2018
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NatImmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Novo HoldingsHolding CompanyHellerup, DenmarkOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)